Eli Lilly starts late-stage trial for Covid-19 antibody drug in nursing homes

0
74

Eli Lilly starts late-stage trial for Covid-19 antibody drug in nursing homes

Eli Lilly is starting its phase three trial in long-term care facilities in partnership with the National Institute of Allergy and Infectious Diseases. The drug is designed to prevent disease in high risk settings such as nursing homes. CNBC’s Meg Tirrell reports.